
India Advances Indigenous Dengue Vaccine as DengiAll Enters Phase III Trials
India is advancing the development of its own dengue vaccine as homegrown candidate DengiAll moves through Phase III clinical trials, potentially adding a domestically developed option to the country’s efforts to address the growing burden of dengue. The development comes…




